3 Clinical Trials for Various Conditions
This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.
To evaluate the safety and efficacy of EB-001 compared to placebo in subjects with glabellar frown lines (GL).
AI-09 In Subjects with Glabellar Lines